Brooks Laboratories [BROOKS] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Brooks Laboratories wins in 5 metrics, Divi's Laboratories wins in 14 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Brooks Laboratories Divi's Laboratories Better
P/E Ratio (TTM) 270.26 70.61 Divi's Laboratories
Price-to-Book Ratio 3.50 10.85 Brooks Laboratories
Debt-to-Equity Ratio 7.73 0.03 Divi's Laboratories
PEG Ratio -0.61 2.67 Brooks Laboratories
EV/EBITDA 49.02 51.72 Brooks Laboratories
Profit Margin (TTM) 2.25% 23.89% Divi's Laboratories
Operating Margin (TTM) 10.72% 25.60% Divi's Laboratories
EBITDA Margin (TTM) 10.72% 25.60% Divi's Laboratories
Return on Equity -10.16% 14.64% Divi's Laboratories
Return on Assets (TTM) -8.06% 12.94% Divi's Laboratories
Free Cash Flow (TTM) $15.98M $2.15B Divi's Laboratories
Dividend Yield N/A 0.91% N/A
1-Year Return -9.07% -0.17% Divi's Laboratories
Price-to-Sales Ratio (TTM) 4.24 16.83 Brooks Laboratories
Enterprise Value $3.83B $1,585.32B Divi's Laboratories
EV/Revenue Ratio 4.25 16.43 Brooks Laboratories
Gross Profit Margin (TTM) 37.71% 60.33% Divi's Laboratories
Revenue per Share (TTM) $32 $363 Divi's Laboratories
Earnings per Share (Diluted) $0.47 $86.68 Divi's Laboratories
Beta (Stock Volatility) 0.77 0.18 Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Brooks Laboratories vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Brooks Laboratories-4.69%-3.24%-10.19%-10.16%5.78%-28.73%
Divi's Laboratories5.59%4.53%2.16%-12.19%13.85%0.97%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Brooks Laboratories-9.07%21.19%114.15%112.06%272.76%272.76%
Divi's Laboratories-0.17%71.63%90.28%473.27%1,615.72%8,449.92%

News Based Sentiment: Brooks Laboratories vs Divi's Laboratories

Brooks Laboratories

News based Sentiment: NEGATIVE

October was a difficult month for Brooks Laboratories, with a significant divergence between standalone and consolidated profits, coupled with a substantial stock price decline. While standalone results were positive, the overall picture is concerning, making this a significant month for investors to reassess their positions.

View Brooks Laboratories News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

October brought both positive developments – strong earnings, the Biosecure Act benefit, and strategic diversification – and negative signals like a block deal and mixed analyst ratings. This creates a complex investment picture requiring careful consideration of both opportunities and risks.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Brooks Laboratories vs Divi's Laboratories

MetricBROOKSDIVISLAB
Market Information
Market Cap i₹3.86B₹1.68T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i37,953535,714
90 Day Avg. Volume i41,401409,930
Last Close₹124.81₹6,474.50
52 Week Range₹95.55 - ₹198.86₹4,955.00 - ₹7,071.50
% from 52W High-37.24%-8.44%
All-Time High₹198.86 (Jan 06, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-37.24%-8.44%
Growth Metrics
Quarterly Revenue Growth0.42%0.14%
Quarterly Earnings Growth0.42%0.27%
Financial Health
Profit Margin (TTM) i0.02%0.24%
Operating Margin (TTM) i0.11%0.26%
Return on Equity (TTM) i-0.10%0.15%
Debt to Equity (MRQ) i7.730.03
Cash & Liquidity
Book Value per Share (MRQ)₹36.34₹563.87
Cash per Share (MRQ)₹0.42₹132.86
Operating Cash Flow (TTM) i₹-42,666,000₹19.67B
Levered Free Cash Flow (TTM) i₹-99,670,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Brooks Laboratories vs Divi's Laboratories

MetricBROOKSDIVISLAB
Price Ratios
P/E Ratio (TTM) i270.2670.61
Forward P/E i21.86108.71
PEG Ratio i-0.612.67
Price to Sales (TTM) i4.2416.83
Price to Book (MRQ) i3.5010.85
Market Capitalization
Market Capitalization i₹3.86B₹1.68T
Enterprise Value i₹3.83B₹1.59T
Enterprise Value Metrics
Enterprise to Revenue i4.2516.43
Enterprise to EBITDA i49.0251.72
Risk & Other Metrics
Beta i0.770.18
Book Value per Share (MRQ) i₹36.34₹563.87

Financial Statements Comparison: Brooks Laboratories vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BROOKSDIVISLAB
Revenue/Sales i₹255.12M₹24.10B
Cost of Goods Sold i₹158.93M₹9.56B
Gross Profit i₹96.19M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹27.35M₹6.17B
EBITDA i₹102.78M₹8.48B
Pre-Tax Income i₹95.85M₹7.33B
Income Tax i₹0₹1.88B
Net Income (Profit) i₹95.85M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BROOKSDIVISLAB
Cash & Equivalents i₹434,000₹4.15B
Total Current Assets i₹338.77M₹100.81B
Total Current Liabilities i₹228.44M₹14.52B
Long-Term Debt i₹13.70M₹20.00M
Total Shareholders Equity i₹981.04M₹149.69B
Retained Earnings i₹-486.52M₹134.00B
Property, Plant & Equipment i₹3.45M₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BROOKSDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBROOKSDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i37,953535,714
Average Daily Volume (90 Day) i41,401409,930
Shares Outstanding i29.46M265.47M
Float Shares i13.55M120.77M
% Held by Insiders i0.56%0.52%
% Held by Institutions i0.10%0.29%

Dividend Analysis & Yield Comparison: Brooks Laboratories vs Divi's Laboratories

MetricBROOKSDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025